{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:28:59Z","timestamp":1792700939843,"version":"4.5.0"},"reference-count":142,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2019,1,25]]},"abstract":"<jats:sec><jats:title\/><jats:p>Disintegrins are non-enzymatic proteins that interfere on cell\u2013cell interactions and signal transduction, contributing to the toxicity of snake venoms and play an essential role in envenomations. Most of their pharmacological and toxic effects are the result of the interaction of these molecules with cell surface ligands, which has been widely described and studied. These proteins may act on platelets, leading to hemorrhage, and may also induce apoptosis and cytotoxicity, which highlights a high pharmacological potential for the development of thrombolytic and antitumor agents. Additionally, these molecules interfere with the functions of integrins by altering various cellular processes such as migration, adhesion and proliferation. This review gathers information on functional characteristics of disintegrins isolated from snake venoms, emphasizing a comprehensive view of the possibility of direct use of these molecules in the development of new drugs, or even indirectly as structural models.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389450119666181022154737","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T04:28:17Z","timestamp":1540441697000},"page":"465-477","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Snake Venom Disintegrins: An Overview of their Interaction with Integrins"],"prefix":"10.2174","volume":"20","author":[{"given":"Pedro Henrique Souza","family":"Cesar","sequence":"first","affiliation":[{"name":"Department of Chemistry, Biochemistry Laboratory, Federal University of Lavras (UFLA), Lavras, Minas Gerais, 37200-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Aparecida","family":"Braga","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Biochemistry Laboratory, Federal University of Lavras (UFLA), Lavras, Minas Gerais, 37200-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vinicius Cardoso","family":"Trento","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Biochemistry Laboratory, Federal University of Lavras (UFLA), Lavras, Minas Gerais, 37200-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo Luccas","family":"Menaldo","sequence":"additional","affiliation":[{"name":"Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeir\u00e3o Preto, University of Sao Paulo (FCFRP-USP), Ribeir\u00e3o Preto-SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Marcussi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Biochemistry Laboratory, Federal University of Lavras (UFLA), Lavras, Minas Gerais, 37200-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.toxicon.2017.11.006","volume":"141","author":"Jimenez R.","year":"2018","unstructured":"Jimenez R, Ikonomopoulou MP, Lopez JA, Miles JJ. Immune drug discovery from venoms.","journal-title":"Toxicon"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00204-008-0358-y","volume":"83","author":"S\u00e1nchez E.E.","year":"2009","unstructured":"S\u00e1nchez EE, Rodr\u00edguez-Acosta A, Palomar R. Colombistatin: A disintegrin isolated from the venom of the South American snake () that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion.","journal-title":"Arch Toxicol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1093\/molbev\/msn179","volume":"25","author":"Ju\u00e1rez P.","year":"2008","unstructured":"Ju\u00e1rez P, Comas I, Gonz\u00e1lez-Candelas F, Calvete JJ. Evolution of snake venom disintegrins by positive darwinian selection.","journal-title":"Mol Biol Evol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.toxicon.2011.01.006","volume":"57","author":"Sajevic T.","year":"2011","unstructured":"Sajevic T, Leonardi A, Kri\u017eaj I. Haemostatically active proteins in snake venoms.","journal-title":"Toxicon"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2012.09.005","volume":"62","author":"Calvete J.J.","year":"2013","unstructured":"Calvete JJ. The continuing saga of snake venom disintegrins.","journal-title":"Toxicon"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bcmd.2006.03.001","volume":"36","author":"Du X.Y.","year":"2006","unstructured":"Du XY, Sim DS, Lee WH, Zhang Y. Blood cells as targets of snake toxins.","journal-title":"Blood Cells Mol Dis"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.toxicon.2015.08.006","volume":"104","author":"Lima-dos-Santos I.","year":"2015","unstructured":"Lima-dos-Santos I, Della-Casa MS, Portes-Junior JA. Characterization of Neuwiedin, a new disintegrin from venom gland with distinct cysteine pattern.","journal-title":"Toxicon"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.toxicon.2005.02.024","volume":"45","author":"Calvete J.J.","year":"2005","unstructured":"Calvete JJ, Marcinkiewicz C, Monle\u00f3n D. Snake venom disintegrins: Evolution of structure and function.","journal-title":"Toxicon"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1042\/bj20021739","volume":"372","author":"Calvete J.J.","year":"2003","unstructured":"Calvete JJ, Moreno-Murciano MP, Theakston RDG, Kisiel DG, Marcinkiewicz C. Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering.","journal-title":"Biochem J"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.toxicon.2011.07.004","volume":"58","author":"Walsh E.M.","year":"2011","unstructured":"Walsh EM, Marcinkiewicz C. Non-RGD-containing snake venom disintegrins, functional and structural relations.","journal-title":"Toxicon"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers9070078","volume":"9","author":"Tolomelli A.","year":"2017","unstructured":"Tolomelli A, Galletti P, Baiula M, Giacomini D. Can integrin agonists have cards to play against cancer? A literature survey of small molecules integrin activators.","journal-title":"Cancers (Basel)"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.biochi.2014.10.010","volume":"107","author":"Angulo Y.","year":"2014","unstructured":"Angulo Y, Castro A, Lomonte B. Isolation and characterization of four medium-size disintegrins from the venoms of Central American viperid snakes of the genera and","journal-title":"Biochimie"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/febs.13138","volume":"282","author":"Carbajo R.J.","year":"2015","unstructured":"Carbajo RJ, Sanz L, Perez A, Calvete JJ. NMR structure of bitistatin - a missing piece in the evolutionary pathway of snake venom disintegrins.","journal-title":"FEBS J"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"20233","DOI":"10.1016\/S0021-9258(17)31981-6","volume":"269","author":"Pfaff M.","year":"1994","unstructured":"Pfaff M, Tangemann K, M\u00fcller B. Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins.","journal-title":"J Biol Chem"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BJ20081403","volume":"417","author":"Brown M.C.","year":"2009","unstructured":"Brown MC, Eble JA, Calvete JJ, Marcinkiewicz C. Structural requirements of KTS-disintegrins for inhibition of alpha(1)beta(1) integrin.","journal-title":"Biochem J"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"37809","DOI":"10.1074\/jbc.274.53.37809","volume":"274","author":"Wierzbicka-Patynowski I.","year":"1999","unstructured":"Wierzbicka-Patynowski I, Niewiarowski S, Marcinkiewicz C. Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins.","journal-title":"J Biol Chem"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj3350247","volume":"335","author":"Rahman S.","year":"1998","unstructured":"Rahman S, Aitken A, Flynn G, Formstone C, Savidge GF. Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn cation.","journal-title":"Biochem J"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1021\/bi035853t","volume":"43","author":"Bazan-Socha S.","year":"2004","unstructured":"Bazan-Socha S, Kisiel DG, Young B. Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins.","journal-title":"Biochem"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1538-7836.2005.01358.x","volume":"3","author":"Lu Q.","year":"2005","unstructured":"Lu Q, Clemetson JM, Clemetson KJ. Snake venoms and hemostasis.","journal-title":"J Thromb Haemost"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"Desgrosellier J.S.","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities.","journal-title":"Nat Rev Cancer"},{"key":"ref=21","first-page":"1","volume":"12","author":"Monti M.","year":"2017","unstructured":"Monti M, Iommelli F, Rosa V. Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells.","journal-title":"PLoS One"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrm2799","volume":"10","author":"Caswell P.T.","year":"2009","unstructured":"Caswell PT, Vadrevu S, Norman JC. Integrins: masters and slaves of endocytic transport.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1242\/jcs.039446","volume":"122","author":"Huveneers S.","year":"2009","unstructured":"Huveneers S, Danen EHJ. Adhesion signaling - crosstalk between integrins, Src and Rho.","journal-title":"J Cell Sci"},{"key":"ref=24","first-page":"1","volume":"18","author":"Ata R.","year":"2017","unstructured":"Ata R, Antonescu CN. Integrins and cell metabolism: An intimate relationship impacting cancer.","journal-title":"Int J Mol Sci"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00441-009-0834-6","volume":"339","author":"Barczyk M.","year":"2010","unstructured":"Barczyk M, Carracedo S, Gullberg D. Integrins.","journal-title":"Cell Tissue Res"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-015-1659-2","volume":"5","author":"Pan L.","year":"2016","unstructured":"Pan L, Zhao Y, Yuan Z, Qin G. Research advances on structure and biological functions of integrins.","journal-title":"Springerplus"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/gb-2007-8-5-215","volume":"8","author":"Takada Y.","year":"2007","unstructured":"Takada Y, Ye X, Simon S. The integrins.","journal-title":"Genome Biol"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1593\/neo.07898","volume":"10","author":"Rosenow F.","year":"2008","unstructured":"Rosenow F, Ossig R, Thormeyer D. Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis [corrected].","journal-title":"Neoplasia"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"17140","DOI":"10.18632\/oncotarget.15084","volume":"8","author":"El Kharbili M.","year":"2017","unstructured":"El Kharbili M, Robert C, Witkowski T. Tetraspanin 8 is a novel regulator of ILK-driven \u03b21 integrin adhesion and signaling in invasive melanoma cells.","journal-title":"Oncotarget"},{"key":"ref=30","volume":"1","author":"Weis S.M.","year":"2011","unstructured":"Weis SM, Cheresh DA. \u03b1V Integrins in angiogenesis and cancer.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/lrb.2008.1011","volume":"6","author":"Garmy-Susini B.","year":"2008","unstructured":"Garmy-Susini B, Varner JA. Roles of integrins in tumor angiogenesis and lymphangiogenesis.","journal-title":"Lymphat Res Biol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrd.2015.10","volume":"15","author":"Ley K.","year":"2016","unstructured":"Ley K, Rivera-Nieves J, Sandborn WJ, Shattil S. Integrin-based therapeutics: Biological basis, clinical use and new drugs.","journal-title":"Nat Rev Drug Discov"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10456-009-9141-9","volume":"12","author":"Somanath P.R.","year":"2009","unstructured":"Somanath PR, Malinin NL, Byzova TV. Cooperation between integrin \u03b1\u03bd\u03b23 and VEGFR2 in angiogenesis.","journal-title":"Angiogenesis"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ceb.2016.07.008","volume":"42","author":"Demircioglu F.","year":"2016","unstructured":"Demircioglu F, Hodivala-Dilke K. \u03b1v\u03b23 Integrin and tumour blood vessels-learning from the past to shape the future.","journal-title":"Curr Opin Cell Biol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canlet.2013.10.019","volume":"344","author":"Zhao F.","year":"2014","unstructured":"Zhao F, Li L, Guan L. Roles for GP IIb\/IIIa and \u03b1v\u03b23 integrins in MDA-MB-231 cell invasion and shear flow-induced cancer cell mechanotransduction.","journal-title":"Cancer Lett"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCRESAHA.112.300570","volume":"112","author":"Bledzka K.","year":"2013","unstructured":"Bledzka K, Smyth SS, Plow EF. Integrin\u03b1 IIb\u03b23: From discovery to efficacious therapeutic target.","journal-title":"Circ Res"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0003-9861(03)00298-4","volume":"416","author":"Cominetti M.R.","year":"2003","unstructured":"Cominetti MR, Ribeiro JU, Fox JW, Selistre-de-Araujo HS. BaG, a new dimeric metalloproteinase\/disintegrin from the snake venom that interacts with alpha5beta1 integrin.","journal-title":"Arch Biochem Biophys"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/cancers5010027","volume":"5","author":"Schaffner F.","year":"2013","unstructured":"Schaffner F, Ray A, Dontenwill M. Integrin \u03b15\u03b21, the fibronectin receptor, as a pertinent therapeutic target in solid tumors.","journal-title":"Cancers (Basel)"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s12094-013-1133-y","volume":"16","author":"Ren J.","year":"2014","unstructured":"Ren J, Xu S, Guo D, Zhang J, Liu S. Increased expression of \u03b15\u03b21-integrin is a prognostic marker for patients with gastric cancer.","journal-title":"Clin Transl Oncol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1590\/S0100-879X2005001000008","volume":"38","author":"Barja-Fidalgo C.","year":"2005","unstructured":"Barja-Fidalgo C, Coelho ALJ, Saldanha-Gama R. Disintegrins: integrin selective ligands which activate integrin-coupled signaling and modulate leukocyte functions.","journal-title":"Braz J Med Biol Res"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-540-78281-0_6","volume":"180","author":"R\u00fcegg C.","year":"2010","unstructured":"R\u00fcegg C, Alghisi GC. Vascular integrins: therapeutic and imaging targets of tumor angiogenesis.","journal-title":"Recent Results Cancer Res"},{"key":"ref=42","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8070206","volume":"8","author":"Hammouda M.","year":"2016","unstructured":"Hammouda M, Montenegro M, S\u00e1nchez-del-Campo I. Lebein, a snake venom disintegrin, induces apoptosis in human melanoma cells.","journal-title":"Toxins (Basel)"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2016.04.020","volume":"143","author":"Hsu C.C.","year":"2016","unstructured":"Hsu CC, Chuang WJ, Chung CH. Improved antithrombotic activity and diminished bleeding side effect of a PEGylated \u03b1IIb\u03b23 antagonist, disintegrin.","journal-title":"Thromb Res"},{"key":"ref=44","author":"Markland F.S.","year":"Applications of snake toxins in biomedicine, in: Venom genomics and proteomics. Springer Netherlands, Dordrecht. 2016;","unstructured":"Markland FS, Swenson SD."},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/CIRCULATIONAHA.115.015711","volume":"131","author":"Arroyo A.G.","year":"2015","unstructured":"Arroyo AG, Andr\u00e9s V. ADAMTS7 in cardiovascular disease.","journal-title":"Circulation"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/gps.4020","volume":"29","author":"Manzine P.R.","year":"2014","unstructured":"Manzine PR, Barham EJ, Vale FAC. Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer\u2019s disease.","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/920942","volume":"2014","author":"Ribeiro de Queiroz M.","year":"2014","unstructured":"Ribeiro de Queiroz M, Mamede CCN, Morais NCG. Purification and characterization of BmooAi: A new toxin from snake venom that inhibits platelet aggregation.","journal-title":"BioMed Res Int"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.toxicon.2005.02.013","volume":"45","author":"Laing G.D.","year":"2005","unstructured":"Laing GD, Moura-da-Silva AM. Jararhagin and its multiple effects on hemostasis.","journal-title":"Toxicon"},{"key":"ref=49","author":"Huang T.F.","year":"2016","unstructured":"Huang TF, Hsu CC, Kuo YJ. Anti-thrombotic agents derived from snake venom proteins.","journal-title":"Thromb J"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.thromres.2010.06.006","volume":"126","author":"S\u00e1nchez E.E.","year":"2010","unstructured":"S\u00e1nchez EE, Lucena SE, Reyes S. Cloning, expression, and hemostatic activities of a disintegrin, r-mojastin 1, from the mohave rattlesnake ().","journal-title":"Thromb Res"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/bjh.14591","volume":"177","author":"Slagboom J.","year":"2017","unstructured":"Slagboom J, Kool J, Harrison RA, Casewell NR. Haemotoxic snake venoms: Their functional activity, impact on snakebite victims and pharmaceutical promise.","journal-title":"Br J Haematol"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.thromres.2013.09.031","volume":"132","author":"McCleary R.J.R.","year":"2013","unstructured":"McCleary RJR, Kini RM. Snake bites and hemostasis\/thrombosis.","journal-title":"Thromb Res"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxicon.2012.09.003","volume":"62","author":"Serrano S.M.T.T.","year":"2013","unstructured":"Serrano SMTT. The long road of research on snake venom serine proteinases.","journal-title":"Toxicon"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1182\/blood-2016-02-695445","volume":"127","author":"Fu J.","year":"2016","unstructured":"Fu J, Xia L. CLEC-2 and podoplanin, partners again.","journal-title":"Blood"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/jth.12519","volume":"12","author":"Chang C.H.","year":"2014","unstructured":"Chang CH, Chung CH, Hsu CC, Peng HC, Huang TF. Inhibitory effects of polypeptides derived from a snake venom C-type lectin, aggretin, on tumor cell-induced platelet aggregation.","journal-title":"J Thromb Haemost"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.toxicon.2005.02.026","volume":"45","author":"Kamiguti A.S.","year":"2005","unstructured":"Kamiguti AS. Platelets as targets of snake venom metalloproteinases.","journal-title":"Toxicon"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cbpc.2005.11.005","volume":"142","author":"Ramos O.H.P.","year":"2006","unstructured":"Ramos OHP, Selistre-de-Araujo HS. Snake venom metalloproteases-structure and function of catalytic and disintegrin domains.","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.toxicon.2011.03.017","volume":"59","author":"Koh C.Y.","year":"2012","unstructured":"Koh CY, Kini RM. From snake venom toxins to therapeutics \u2013 Cardiovascular examples.","journal-title":"Toxicon"},{"key":"ref=59","author":"Dolgos H.","year":"2016","unstructured":"Dolgos H, Freisleben A, Wimmer E. and drug disposition of cilengitide in animals and human.","journal-title":"Pharmacol Res Perspect"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/1078-0432.CCR-13-1504","volume":"20","author":"Allen M.D.","year":"2014","unstructured":"Allen MD, Thomas GJ, Clark S. Altered microenvironment promotes progression of preinvasive breast cancer: Myoepithelial expression of v 6 integrin in DCIS identifies high-risk patients and predicts recurrence.","journal-title":"Clin Cancer Res"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/ijc.28267","volume":"133","author":"Vogetseder A.","year":"2013","unstructured":"Vogetseder A, Thies S, Ingold B. \u03b1v-Integrin isoform expression in primary human tumors and brain metastases.","journal-title":"Int J Cancer"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","volume":"25","author":"Seguin L.","year":"2015","unstructured":"Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.","journal-title":"Trends Cell Biol"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"Carmeliet P.","year":"2005","unstructured":"Carmeliet P. Angiogenesis in life, disease and medicine.","journal-title":"Nature"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/1389203716666150515125002","volume":"16","author":"Arruda Mac\u00eado J.K.","year":"2015","unstructured":"Arruda Mac\u00eado JK, Fox JW, de Souza Castro M. Disintegrins from snake venoms and their applications in cancer research and therapy.","journal-title":"Curr Protein Pept Sci"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0304-4165(97)00057-3","volume":"1336","author":"Sheu J.R.","year":"1997","unstructured":"Sheu JR, Yen MH, Kan YC. Inhibition of angiogenesis and : Comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.","journal-title":"Biochim Biophys Acta"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1074\/jbc.274.18.12468","volume":"274","author":"Marcinkiewicz C.","year":"1999","unstructured":"Marcinkiewicz C, Calvete JJ, Marcinkiewicz MM. EC3, a novel heterodimeric disintegrin from venom, inhibits alpha4 and alpha5 integrins in an RGD-independent manner.","journal-title":"J Biol Chem"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0049-3848(01)00416-9","volume":"105","author":"Hong S.Y.","year":"2002","unstructured":"Hong SY, Koh YS, Chung KH, Kim DS. Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration.","journal-title":"Thromb Res"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.febslet.2004.10.050","volume":"577","author":"Kisiel D.G.","year":"2004","unstructured":"Kisiel DG, Calvete JJ, Katzhendler J. Structural determinants of the selectivity of KTS-disintegrins for the alpha1beta1 integrin.","journal-title":"FEBS Lett"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.toxicon.2013.12.006","volume":"79","author":"Bol\u00e1s G.","year":"2014","unstructured":"Bol\u00e1s G, de Rezende FF, Lorente C. Inhibitory effects of recombinant RTS-jerdostatin on integrin \u03b11\u03b21 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.","journal-title":"Toxicon"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.toxicon.2010.07.013","volume":"56","author":"Ju\u00e1rez P.","year":"2010","unstructured":"Ju\u00e1rez P, Bol\u00e1s G, de Rezende FF, Calvete JJ, Eble JA. Recombinant expression in human cells of active integrin \u03b11\u03b21-blocking RTS-disintegrin jerdostatin.","journal-title":"Toxicon"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.5604\/17322693.1131696","volume":"68","author":"Bazan-Socha S.","year":"2014","unstructured":"Bazan-Socha S, \u017buk J, Plutecka H. Blocking of \u03b11\u03b21 and \u03b12\u03b21 adhesion molecules inhibits eosinophil migration through human lung microvascular endothelial cell monolayer.","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4161\/cbt.8.15.8999","volume":"8","author":"Staniszewska I.","year":"2009","unstructured":"Staniszewska I, Walsh EM, Rothman VL. Effect of VP12 and viperistatin on inhibition of collagen-receptor-dependent melanoma metastasis.","journal-title":"Cancer Biol Ther"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1227\/01.NEU.0000163426.25227.56","volume":"57","author":"Schmitmeier S.","year":"2005","unstructured":"Schmitmeier S, Markland FS, Sch\u00f6nthal AH, Chen TC. Potent mimicry of fibronectin-induced intracellular signaling in glioma cells by the homodimeric snake venom disintegrin contortrostatin.","journal-title":"Neurosurgery"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.toxicon.2011.02.020","volume":"59","author":"Minea R.","year":"2012","unstructured":"Minea R, Helchowski C, Rubino B. Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential.","journal-title":"Toxicon"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/bbrc.2000.3130","volume":"275","author":"Kang I.C.","year":"2000","unstructured":"Kang IC, Kim DS, Jang Y, Chung KH. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0006-291X(03)00213-4","volume":"302","author":"Hong S.Y.","year":"2003","unstructured":"Hong SY, Lee H, You WK. The snake venom disintegrin salmosin induces apoptosis by disassembly of focal adhesions in bovine capillary endothelial cells.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jbiosc.2010.03.013","volume":"110","author":"Min C.K.","year":"2010","unstructured":"Min CK, Lee JW, Chung KH, Park HW. Control of specific growth rate to enhance the production of a novel disintegrin, saxatilin, in recombinant","journal-title":"J Biosci Bioeng"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bcp.2015.08.088","volume":"97","author":"Colinas O.","year":"2015","unstructured":"Colinas O, Moreno-Dom\u00ednguez A, Zhu HL. \u03b15-Integrin-mediated cellular signaling contributes to the myogenic response of cerebral resistance arteries.","journal-title":"Biochem Pharmacol"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/203639","volume":"2014","author":"Calderon L.A.","year":"2014","unstructured":"Calderon LA, Sobrinho JC, Zaqueo KD. Antitumoral activity of snake venom proteins: new trends in cancer therapy.","journal-title":"BioMed Res Int"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrc3792","volume":"14","author":"Sulzmaier F.J.","year":"2014","unstructured":"Sulzmaier FJ, Jean C, Schlaepfer DD. FAK in cancer: Mechanistic findings and clinical applications.","journal-title":"Nat Rev Cancer"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1540-8183.2011.00632.x","volume":"24","author":"Mahmoudi M.","year":"2011","unstructured":"Mahmoudi M, Delhaye C, Wakabayashi K. Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.","journal-title":"J Interv Cardiol"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijbiomac.2016.04.008","volume":"88","author":"Saviola A.J.","year":"2016","unstructured":"Saviola AJ, Burns PD, Mukherjee AK, Mackessy SP. The disintegrin tzabcanin inhibits adhesion and migration in melanoma and lung cancer cells.","journal-title":"Int J Biol Macromol"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00125-016-3933-4","volume":"59","author":"Pellegrinelli V.","year":"2016","unstructured":"Pellegrinelli V, Carobbio S, Vidal-Puig A. Adipose tissue plasticity: How fat depots respond differently to pathophysiological cues.","journal-title":"Diabetologia"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1160\/TH16-01-0015","volume":"116","author":"Bauters D.","year":"2016","unstructured":"Bauters D, Scroyen I, Deprez-Poulain R, Lijnen HR. ADAMTS5 promotes murine adipogenesis and visceral adipose tissue expansion.","journal-title":"Thromb Haemost"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2016.05.005","volume":"119","author":"Lin D.","year":"2016","unstructured":"Lin D, Chun TH, Kang L. Adipose extracellular matrix remodelling in obesity and insulin resistance.","journal-title":"Biochem Pharmacol"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bcp.2005.07.035","volume":"70","author":"Lin Y.T.","year":"2005","unstructured":"Lin YT, Tang CH, Chuang WJ. Inhibition of adipogenesis by RGD-dependent disintegrin.","journal-title":"Biochem Pharmacol"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.abb.2007.10.002","volume":"468","author":"Sanchez E.F.","year":"2007","unstructured":"Sanchez EF, Gabriel LM, Gontijo S. Structural and functional characterization of a P-III metalloproteinase, leucurolysin-B, from venom.","journal-title":"Arch Biochem Biophys"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/bbrc.1999.1897","volume":"267","author":"Brando C.","year":"2000","unstructured":"Brando C, Marcinkiewicz C, Goldman B, McLane MA, Niewiarowski S. EC3, a heterodimeric disintegrin from , inhibits human and murine alpha4 integrin and attenuates lymphocyte infiltration of Langerhans islets in pancreas and salivary glands in nonobese diabetic mice.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.yexcr.2003.09.013","volume":"292","author":"Coelho A.L.J.","year":"2004","unstructured":"Coelho ALJ, Freitas MS, Mariano-Oliveira A. RGD- and MLD-disintegrins, jarastatin and EC3, activate integrin-mediated signaling modulating the human neutrophils chemotaxis, apoptosis and IL-8 gene expression.","journal-title":"Exp Cell Res"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-62703-670-2_1","volume":"1087","author":"Cicala C.","year":"2014","unstructured":"Cicala C, Arthos J. Virion attachment and entry: HIV gp120 Env biotinylation, gp120 Env, or integrin ligand-binding assay.","journal-title":"Methods Mol Biol"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4049\/jimmunol.1300661","volume":"191","author":"Racicot K.","year":"2013","unstructured":"Racicot K, Cardenas I, Wunsche V. Viral infection of the pregnant cervix predisposes to ascending bacterial infection.","journal-title":"J Immunol"},{"key":"ref=92","author":"Li C","year":"The Immune adaptor ADAP regulates reciprocal TGF-\u03b21-Integrin crosstalk to protect from Influenza virus infection. PLOS Pathog 2015; 11(4): doi:10.1371\/journal. ppat.1004824","unstructured":"Li C, Jiao S, Wang G."},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neulet.2004.06.035","volume":"368","author":"Fu W.M.","year":"2004","unstructured":"Fu WM, Chang TK, Sun WZ. Inhibition of neuropathic pain by a potent disintegrin--triflavin.","journal-title":"Neurosci Lett"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1093\/nar\/18.14.4255","volume":"18","author":"Neeper M.P.","year":"1990","unstructured":"Neeper MP, Jacobson MA. Sequence of a cDNA encoding the platelet aggregation inhibitor trigramin.","journal-title":"Nucleic Acids Res"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0049-3848(94)90052-3","volume":"73","author":"Trikha M.","year":"1994","unstructured":"Trikha M, Rote WE, Manley PJ, Lucchesi BR, Markland FS. Purification and characterization of platelet aggregation inhibitors from snake venoms.","journal-title":"Thromb Res"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cbpc.2004.06.012","volume":"139","author":"Zhou X.D.","year":"2004","unstructured":"Zhou XD, Ding CH, Tai H. A novel disintegrin, jerdonatin, inhibits platelet aggregation and sperm\u2013egg binding.","journal-title":"Comp Biochem Physiol Part B Biochem Mol Biol"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"26488","DOI":"10.1074\/jbc.M301860200","volume":"278","author":"Eble J.A.","year":"2003","unstructured":"Eble JA, Bruckner P, Mayer U. venom contains two disintegrins inhibiting Laminin-binding 1 integrins.","journal-title":"J Biol Chem"},{"key":"ref=98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010929","volume":"5","author":"Minea R.O.","year":"2010","unstructured":"Minea RO, Helchowski CM, Zidovetzki SJ. Vicrostatin \u2013 an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.","journal-title":"PLoS One"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.toxicon.2008.02.004","volume":"51","author":"Gal\u00e1n J.A.","year":"2008","unstructured":"Gal\u00e1n JA, S\u00e1nchez EE, Rodr\u00edguez-Acosta A. Inhibition of lung tumor colonization and cell migration with the disintegrin crotatroxin 2 isolated from the venom of","journal-title":"Toxicon"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.toxicon.2003.10.023","volume":"43","author":"Zhou X.D.","year":"2004","unstructured":"Zhou XD, Jin Y, Chen RQ. Purification, cloning and biological characterization of a novel disintegrin from venom.","journal-title":"Toxicon"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1006\/jmbi.1993.1439","volume":"232","author":"Senn H.","year":"1993","unstructured":"Senn H, Klaus W. The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor.","journal-title":"J Mol Biol"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.taap.2005.07.004","volume":"212","author":"S\u00e1nchez E.E.","year":"2006","unstructured":"S\u00e1nchez EE, Gal\u00e1n JA, Russell WK. Isolation and characterization of two disintegrins inhibiting ADP-induced human platelet aggregation from the venom of (Mohave Rattlesnake).","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.toxicon.2012.03.011","volume":"60","author":"Lucena S.E.","year":"2012","unstructured":"Lucena SE, Jia Y, Soto JG. Anti-invasive and anti-adhesive activities of a recombinant disintegrin, r-viridistatin 2, derived from the ().","journal-title":"Toxicon"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jmb.2004.06.048","volume":"341","author":"Bilgrami S.","year":"2004","unstructured":"Bilgrami S, Tomar S, Yadav S. Crystal structure of schistatin, a disintegrin homodimer from saw-scaled viper () at 2.5 A resolution.","journal-title":"J Mol Biol"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1107\/S0907444901012082","volume":"57","author":"Tomar S.","year":"2001","unstructured":"Tomar S, Yadav S, Chandra V, Kumar P, Singh TP. Purification, crystallization and preliminary X-ray diffraction studies of disintegrin (schistatin) from saw-scaled viper ().","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10585-007-9101-y","volume":"25","author":"Ramos O.H.P.","year":"2008","unstructured":"Ramos OHP, Kauskot A, Cominetti MR. A novel alpha(v)beta (3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis.","journal-title":"Clin Exp Metastasis"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0304-4165(91)90052-I","volume":"1074","author":"Huang T.F.","year":"1991","unstructured":"Huang TF, Wang WJ, Teng CM, Liu CS, Ouyang C. Purification and characterization of an antiplatelet peptide, arietin, from venom.","journal-title":"Biochim Biophys Acta"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/excr.1999.4583","volume":"251","author":"Coelho A.L.","year":"1999","unstructured":"Coelho AL, Freitas MS, Oliveira-Carvalho AL. Effects of jarastatin, a novel snake venom disintegrin, on neutrophil migration and actin cytoskeleton dynamics.","journal-title":"Exp Cell Res"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood.V92.9.3268","volume":"92","author":"Yeh C.H.","year":"1998","unstructured":"Yeh CH, Peng HC, Huang TF. Accutin, a new disintegrin, inhibits angiogenesis and by acting as integrin alphavbeta3 antagonist and inducing apoptosis.","journal-title":"Blood"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/bj2770351","volume":"277","author":"Huang T.F.","year":"1991","unstructured":"Huang TF, Sheu JR, Teng CM. A potent antiplatelet peptide, triflavin, from snake venom.","journal-title":"Biochem J"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0300-9084(96)82187-0","volume":"78","author":"Kawasaki T.","year":"1996","unstructured":"Kawasaki T, Sakai Y, Taniuchi Y. Biochemical characterization of a new disintegrin, flavostatin, isolated from venom.","journal-title":"Biochimie"},{"key":"ref=112","author":"Williams J","year":"Elegantin and albolabrin purified peptides from viper venoms; homologies with the RGDS domain of fibrinogen and von Willebrand factor. Biochim Biophys Acta - Protein Struct Mol Enzymol 1990; 1039(1): 81-9","unstructured":"Williams J, Rucinski B, Holt J, Niewiarowski S."},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0167-4889(90)90096-V","volume":"1054","author":"Rucinski B.","year":"1990","unstructured":"Rucinski B, Niewiarowski S, Holt JC, Soszka T, Knudsen KA. Batroxostatin, an Arg-Gly-Asp-containing peptide from , is a potent inhibitor of platelet aggregation and cell interaction with fibronectin.","journal-title":"Biochim Biophys Acta"},{"key":"ref=114","first-page":"253","volume":"51","author":"Pinto A.","year":"2003","unstructured":"Pinto A, Angulo Y, Jim\u00e9nez R, Lomonte B. Isolation of bothrasperin, a disintegrin with potent platelet aggregation inhibitory activity, from the venom of the snake","journal-title":"Rev Biol Trop"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/0041-0101(95)00074-V","volume":"33","author":"Liu C.Z.","year":"1995","unstructured":"Liu CZ, Peng HC, Huang TF. Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake","journal-title":"Toxicon"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0006-2952(91)90256-5","volume":"42","author":"Huang T.F.","year":"1991","unstructured":"Huang TF, Liu CZ, Ouyang CH, Teng CM. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.","journal-title":"Biochem Pharmacol"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1432-1033.1994.00861.x","volume":"226","author":"Jaseja M.","year":"1994","unstructured":"Jaseja M, Lu X, Williams JA. 1H-NMR assignments and secondary structure of dendroaspin, an RGD-containing glycoprotein IIb-IIIa (alpha IIb-beta 3) antagonist with a neurotoxin fold.","journal-title":"Eur J Biochem"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0005-2795(79)90101-6","volume":"579","author":"Joubert F.J.","year":"1979","unstructured":"Joubert FJ, Taljaard N. Some properties and the complete primary structures of two reduced and S-carboxymethylated polypeptides (S5C1 and S5C10) from (Jameson\u2019s mamba) venom.","journal-title":"Biochim Biophys Acta"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bbrc.2005.01.148","volume":"329","author":"Fernandez J.H.","year":"2005","unstructured":"Fernandez JH, Silva CA, Assakura MT, Camargo ACM, Serrano SMT. Molecular cloning, functional expression, and molecular modeling of bothrostatin, a new highly active disintegrin from venom.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/oxfordjournals.jbchem.a022264","volume":"125","author":"Oshikawa K.","year":"1999","unstructured":"Oshikawa K, Terada S. Ussuristatin 2, a novel KGD-bearing disintegrin from venom.","journal-title":"J Biochem"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/oxfordjournals.jbchem.a003000","volume":"130","author":"Okuda D.","year":"2001","unstructured":"Okuda D, Morita T. Purification and characterization of a new RGD\/KGD-containing dimeric disintegrin, piscivostatin, from the venom of the unique effect of piscivostatin on platelet aggregation.","journal-title":"J Biochem"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1016\/S0021-9258(18)92826-7","volume":"266","author":"Scarborough R.M.","year":"1991","unstructured":"Scarborough RM, Rose JW, Hsu MA. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of","journal-title":"J Biol Chem"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"19827","DOI":"10.1016\/S0021-9258(19)77710-2","volume":"263","author":"Gan Z.R.","year":"1988","unstructured":"Gan ZR, Gould RJ, Jacobs JW, Friedman PA, Polokoff MA. Echistatin. A potent platelet aggregation inhibitor from the venom of the viper,","journal-title":"J Biol Chem"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jmb.2004.08.009","volume":"342","author":"Hantgan R.R.","year":"2004","unstructured":"Hantgan RR, Stahle MC, Connor JH. The disintegrin echistatin stabilizes integrin alphaIIb beta3\u2019s open conformation and promotes its oligomerization.","journal-title":"J Mol Biol"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-5793(97)01203-9","volume":"416","author":"Calvete J.J.","year":"1997","unstructured":"Calvete JJ, Schrader M, Raida M. The disulphide bond pattern of bitistatin, a disintegrin isolated from the venom of the viper","journal-title":"FEBS Lett"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/bj3010429","volume":"301","author":"McLane M.A.","year":"1994","unstructured":"McLane MA, Kowalska MA, Silver L, Shattil SJ, Niewiarowski S. Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets.","journal-title":"Biochem J"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/BF02256134","volume":"11","author":"Tseng Y.L.","year":"2004","unstructured":"Tseng YL, Peng HC, Huang TF. Rhodostomin, a disintegrin, inhibits adhesion of neutrophils to fibrinogen and attenuates superoxide production.","journal-title":"J Biomed Sci"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-5793(02)02233-0","volume":"512","author":"Smith J.B.","year":"2002","unstructured":"Smith JB, Theakston RDG, Coelho ALJ. Characterization of a monomeric disintegrin, ocellatusin, present in the venom of the Nigerian carpet viper,","journal-title":"FEBS Lett"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"14408","DOI":"10.1021\/bi0300276","volume":"42","author":"Shin J.","year":"2003","unstructured":"Shin J, Hong SY, Chung K. Solution structure of a novel disintegrin, salmosin, from venom.","journal-title":"Biochemistry"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1126\/science.1862345","volume":"253","author":"Adler M.","year":"1991","unstructured":"Adler M, Lazarus RA, Dennis MS, Wagner G. Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist.","journal-title":"Science"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/abbi.1998.0698","volume":"354","author":"Shimokawa K.","year":"1998","unstructured":"Shimokawa K, Jia LG, Shannon JD, Fox JW. Isolation, sequence analysis, and biological activity of atrolysin E\/D, the non-RGD disintegrin domain from venom.","journal-title":"Arch Biochem Biophys"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.toxicon.2011.12.002","volume":"59","author":"Carey C.M.","year":"2012","unstructured":"Carey CM, Bueno R, Gutierrez DA. Recombinant rubistatin (r-Rub), an MVD disintegrin, inhibits cell migration and proliferation, and is a strong apoptotic inducer of the human melanoma cell line SK-Mel-28.","journal-title":"Toxicon"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.1021\/bi9906930","volume":"38","author":"Marcinkiewicz C.","year":"1999","unstructured":"Marcinkiewicz C, Calvete JJ, Vijay-Kumar S. Structural and functional characterization of EMF10, a heterodimeric disintegrin from venom that selectively inhibits alpha5beta 1 integrin.","journal-title":"Biochemistry"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1021\/bi015627o","volume":"41","author":"Calvete J.J.","year":"2002","unstructured":"Calvete JJ, Fox JW, Agelan A, Niewiarowski S, Marcinkiewicz C. The presence of the WGD motif in CC8 heterodimeric disintegrin increases its inhibitory effect on alphaII(b)beta3, alpha(v)beta3, and alpha5beta1 integrins.","journal-title":"Biochem"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-2836(03)00371-1","volume":"329","author":"Moreno-Murciano M.P.","year":"2003","unstructured":"Moreno-Murciano MP, Monle\u00f3n D, Marcinkiewicz C, Calvete JJ, Celda B. NMR solution structure of the non-RGD disintegrin obtustatin.","journal-title":"J Mol Biol"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/labinvest.3700350","volume":"85","author":"Olfa K.Z.","year":"2005","unstructured":"Olfa KZ, Jos\u00e9 L, Salma D. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis.","journal-title":"Lab Invest"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"40714","DOI":"10.1074\/jbc.M509738200","volume":"280","author":"Sanz L.","year":"2005","unstructured":"Sanz L, Chen RQ, P\u00e9rez A. cDNA cloning and functional expression of jerdostatin, a novel RTS-disintegrin from and a specific antagonist of the alpha1beta1 integrin.","journal-title":"J Biol Chem"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.matbio.2013.01.001","volume":"32","author":"Shih C.H.","year":"2013","unstructured":"Shih CH, Chiang TB, Wang WJ. Inhibition of integrins \u03b1v\/\u03b15-dependent functions in melanoma cells by an ECD-disintegrin acurhagin-C.","journal-title":"Matrix Biol"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.toxicon.2011.05.013","volume":"58","author":"Higuchi D.A.","year":"2011","unstructured":"Higuchi DA, Almeida MC, Barros CC. Leucurogin, a new recombinant disintegrin cloned from (white-tailed-jararaca) with potent activity upon platelet aggregation and tumor growth.","journal-title":"Toxicon"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/pr060494k","volume":"6","author":"Calvete J.J.","year":"2007","unstructured":"Calvete JJ, Marcinkiewicz C, Sanz L. Snake venomics of . Protein family composition, subunit organization of venom toxins, and characterization of dimeric disintegrins bitisgabonin-1 and bitisgabonin-2.","journal-title":"J Proteome Res"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"14248","DOI":"10.1021\/bi025876s","volume":"41","author":"Okuda D.","year":"2002","unstructured":"Okuda D, Koike H, Morita T. A new gene structure of the disintegrin family: A subunit of dimeric disintegrin has a short coding region.","journal-title":"Biochem"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-4838(01)00168-6","volume":"1547","author":"Gasmi A.","year":"2001","unstructured":"Gasmi A, Srairi N, Guermazi S. Amino acid structure and characterization of a heterodimeric disintegrin from venom.","journal-title":"Biochim Biophys Acta"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T16:33:27Z","timestamp":1662309207000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166527\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":142,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,1,25]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450119666181022154737","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,25]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}